News Center
Contact us
中文
About Us
Who we are
Our history
Brand culture
Our Businesses
Pharma
Medical
Diagnostics
Vaccines
Sustainability
EHS Responsibility
Education Projects
Charitable Donations
Community Services
Join us
People Strategy
Our People
Job Opportunities
News Center
Boan Reached a Strategic Cooperation for Denosumab in Brazil
2024-11-27
MORE>
First Patient Dosed in Phase 1 Study of Boan’s CD228 ADC
2024-11-20
MORE>
Luye Pharma’s Class 1 Innovative Antidepressant Targeting NET/DAT/GABAAR Approved for Cli...
2024-11-20
MORE>
Luye Pharma Announces 2024 Half Year Results
2024-08-29
MORE>
Boan Biotech Announces 2024 Half Year Results: Revenue Grows by 39%, Net Profit Increases ...
2024-08-28
MORE>
Luye Pharma Announces U.S. FDA Approval of ERZOFRI® for Treating Schizophrenia and Schizoa...
2024-07-30
MORE>
Total:
141
/ Page:
24
First
Prev
1
2
3
4
5
Next
Last
鲁ICP备05023892号-5
LUYE All Rights Reserved
Privacy policy
Terms of use
中文
TOP
TOP